Literature DB >> 25845445

A multinational study to compare prevalence of atopic dermatitis in the first year of life.

Eelco Draaisma1, Luis Garcia-Marcos2,3, Javier Mallol4, Dirceu Solé5, Virginia Pérez-Fernández2, Paul L P Brand1,6.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is common in childhood, with peak prevalence in early childhood. However, international comparisons of prevalence have focused on older children. We analysed differences in prevalence rates of AD and the associations with putative risk and protective factors, among infants in two European and two Central American countries.
METHODS: In 1-yr old infants participating in the International Study of Wheezing in Infants (EISL), prevalence of AD and putative risk and protective factors were assessed by a questionnaire applied to parents. For each risk/protective factor summary, odds ratios with 95% confidence intervals were calculated by means of random effects meta-analysis.
RESULTS: Data from 9803 infants were analysed. AD prevalence varied from 10.6% (Valencia, Spain) to 28.2% (San Pedro Sula, Honduras). Average AD prevalences were lower in Europe (14.2%) than in Central America (18.2%, p < 0.01). Consistent with older children, presence of siblings decreased (OR 0.82 [0.72-0.94]), whereas family history of asthma (OR 1.32 [1.10-1.59]), rhinitis (OR 1.33 [1.14-1.54]) and atopic dermatitis (OR 2.40 [1.89-3.05]) increased the risk of infantile AD. However, gender, family size, breastfeeding and socio-economic status were not associated with AD prevalence.
CONCLUSIONS: This study shows almost threefold differences in the prevalence of AD in infancy between countries. Risk and protective factors involved in the expression of infantile AD differ from those in older children, possibly suggesting a different pathophysiology. There is a need for additional international epidemiological surveys on AD in young children, the peak prevalence age of this condition.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  atopic dermatitis; infants; international; prevalence; protective factors; risk factors

Mesh:

Year:  2015        PMID: 25845445     DOI: 10.1111/pai.12388

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  6 in total

Review 1.  [Red, scaly baby: a pediatric dermatological emergency : Clinical and differential diagnoses of neonatal erythroderma].

Authors:  H Ott; J Grothaus
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

Review 2.  Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes.

Authors:  Tracy Augustine; Manoj Kumar; Souhaila Al Khodor; Nicholas van Panhuys
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

3.  Genetic predisposition and environmental factors associated with the development of atopic dermatitis in infancy: a prospective birth cohort study.

Authors:  Caroline Gallay; Patrick Meylan; Sophie Mermoud; Alexandre Johannsen; Caroline Lang; Carlo Rivolta; Stephanie Christen-Zaech
Journal:  Eur J Pediatr       Date:  2020-03-06       Impact factor: 3.183

4.  Maternal sensitivity and social support protect against childhood atopic dermatitis.

Authors:  Nicole L Letourneau; Anita L Kozyrskyj; Nela Cosic; Henry N Ntanda; Lubna Anis; Martha J Hart; Tavis S Campbell; Gerald F Giesbrecht
Journal:  Allergy Asthma Clin Immunol       Date:  2017-05-26       Impact factor: 3.406

Review 5.  Human Milk and Allergic Diseases: An Unsolved Puzzle.

Authors:  Daniel Munblit; Diego G Peroni; Alba Boix-Amorós; Peter S Hsu; Belinda Van't Land; Melvin C L Gay; Anastasia Kolotilina; Chrysanthi Skevaki; Robert J Boyle; Maria Carmen Collado; Johan Garssen; Donna T Geddes; Ralph Nanan; Carolyn Slupsky; Ganesa Wegienka; Anita L Kozyrskyj; John O Warner
Journal:  Nutrients       Date:  2017-08-17       Impact factor: 5.717

6.  Association of reduced count of interleukin-13-producing cells in breast milk with atopic dermatitis in infancy.

Authors:  Sepideh Moradkhani; Abdollah Jafarzadeh; Nasrin Bazargan-Harandi; Mohammad Reza Baneshi; Mohammad Mahdi Mohammadi
Journal:  Indian J Med Res       Date:  2018-09       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.